ARIA - ARIAD Pharmaceuticals Inc.

ARIA valuation $1.21 billion

Stock Price

6.45
Change: ↑ 0.01 (0.15528%)
Last Update: 2015-01-30T16:15:09-05:00
Shares Outstanding: 187,212,428
Industry: Biotechnology

ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines.

ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers.

ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines.

Stock Price Data

Open: 6.39 Previous Close: 6.44
High: 6.56 Low: 6.301
Bid: 6.42 Ask: 6.46

Bid Size: 200 Ask Size: 200
Raw Bid Size: 2 Raw Ask Size: 2
Trade Volume: 15490 Share Volume: 3570960
Last Trade Date: 2015-01-30 Last Trade Time: 16:14:57-05:00
Vwap: 6.44941093 EPS: -1.24

Fundamental Data

PE ratio: PB ratio: 15.00
Beta: 1.432567

52 Week High: 9.22 52 Week Low: 4.90
52 Week High Vwap: 8.9741 52 Week Low Vwap: 5.0678
52 Week High Volume: 43580151 52 Week Low Volume: 2807829
52 Week Avg Volume: 8748961
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.10
ARNA Arena Pharmaceuticals Inc. 4.31
MNKD MannKind Corporation 6.35
AMGN Amgen Inc 152.26
NVAX Novavax Inc. 7.81
NPSP NPS Pharmaceuticals Inc. 45.86
BIIB Biogen Idec Inc. 388.77
PDLI PDL BioPharma Inc. 7.29
 

Iron FX 1.11156/1.11128 2.8
XM Markets 1.09948/1.09928 2
FxPro 1.10184/1.10171 1.3
FXCM 1.13943/1.13912 3.1